Catalyst Wire Dossier Catalyst Wire Dossier

CNTX-4975-05

· Centrexion Therapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CNTX-4975-05, covering 2022-03-09 to 2022-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain [Phase 3]

See pricing